Taken together, evaluating Ang-2, NGAL, and KIM-1 in combination may improve risk stratification and provide further insights into the underlying mechanisms of AKI, particularly in cases related to rhabdomyolysis. The gene discussed is HAVCR1; the disease is acute kidney injury.